China Food and Beverage Company (CHIF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -90.00 | -120.00 | -2313.00 | -1825.00 | -60.14 Thousand | -32.27 Thousand |
| Net Income | -59.2 Million | -2.39 Million | -1.62 Million | -20.6 Thousand | -60.7 Thousand | -5612.00 |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 59.2 Million | 2.39 Million | 1.59 Million | 18.77 Thousand | 560.00 | -26.66 Thousand |
| Other non-cash items | -14.95 Thousand | -1983.00 | 225.33 Thousand | - | -560.00 | 21.86 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 75.00 | - | 9361.00 | - | 60 Thousand | 32.5 Thousand |
| Debt repayment | -75.00 | - | -9361.00 | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 60 Thousand | 32.5 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | 2007.00 | -12.79 Thousand | - | 560.00 | -21.86 Thousand |
| Accounts payables | 14.95 Thousand | - | -189.93 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 59.19 Million | 2.39 Million | 1.8 Million | 18.77 Thousand | - | -4800.00 |
| Cash at beginning of period | 1.00 | 121.00 | 86.00 | 81.00 | 225.00 | -1.00 |
| Cash at end of period | -14.00 | 1.00 | 121.00 | 86.00 | 81.00 | 225.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -15.00 | -120.00 | 35.00 | 5.00 | -144.00 | 226.00 |
| Free Cash Flow | -90.00 | -120.00 | -2313.00 | -1825.00 | -60.14 Thousand | -32.27 Thousand |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -59.2 Million | -58.29 Million | -300.04 Thousand | -14.3 Thousand | -600.04 Thousand | -2.39 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 59.2 Million | 58.29 Million | 300 Thousand | 14.29 Thousand | 600.06 Thousand | 2.39 Million |
| Other non-cash items | -14.95 Thousand | - | - | - | -60.00 | -1983.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | -5.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 75.00 | 30.00 | 45.00 | - | - | - |
| Debt repayment | -75.00 | -75.00 | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -45.00 | - | - | - | - |
| Accounts receivables | - | - | - | - | 60.00 | 2007.00 |
| Accounts payables | 14.95 Thousand | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 59.19 Million | 58.27 Million | - | 14.29 Thousand | 600 Thousand | 2.39 Million |
| Cash at beginning of period | 1.00 | 1.00 | 1.00 | 16.00 | 1.00 | 121.00 |
| Cash at end of period | -14.00 | -14.00 | 1.00 | 1.00 | 16.00 | 1.00 |
| Capital Expenditure | - | -5.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -15.00 | -15.00 | - | -15.00 | 15.00 | -120.00 |
| Free Cash Flow | -90.00 | -50.00 | -45.00 | -15.00 | 15.00 | -120.00 |
2316
600258
EVROF
MEDC
ADAD
CMO